This inventor holds 1 USPTO granted patent. Top assignee: Mgi Pharma Biologics, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Hongmin Chen
Introduction
Hongmin Chen is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that address inflammation and autoimmunity.
Latest Patents
Hongmin Chen holds a patent for α-MSH related compounds and methods of use. This invention provides polypeptides containing α-MSH that can be utilized to treat diseases characterized by inflammation and/or autoimmunity. The patent also includes α-MSH analogs and nucleic acids encoding polypeptides containing α-MSH and α-MSH analogs, which may be linked to heterologous sequences. Additionally, the invention outlines methods for delivering α-MSH containing peptides, α-MSH analogs, and DNA encoding these compounds.
Career Highlights
Hongmin Chen is currently associated with MGI Pharma Biologics, Inc., where he continues to innovate in the field of biotechnology. His work has the potential to impact the treatment of various inflammatory and autoimmune diseases.
Collaborations
Some of his notable coworkers include Mary Lynne Hedley and Robert G Urban, who contribute to the collaborative environment that fosters innovation at MGI Pharma Biologics, Inc.
Conclusion
Hongmin Chen's contributions to biotechnology through his patent on α-MSH related compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in treating diseases related to inflammation and autoimmunity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile